Early fast‐acting treatment strategy against generalized myasthenia gravis-Reference-Cited by-同舟云学术

Early fast‐acting treatment strategy against generalized myasthenia gravis

Published:2017-02-03 Issue:6 Volume:55 Page:794-801
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle Nerve

Author:

Utsugisawa Kimiaki¹,Nagane Yuriko¹,Akaishi Tetsuya²,Suzuki Yasushi³,Imai Tomihiro⁴,Tsuda Emiko⁴,Minami Naoya⁵,Uzawa Akiyuki⁶,Kawaguchi Naoki⁷,Masuda Masayuki⁸,Konno Shingo⁹,Suzuki Hidekazu¹⁰,Murai Hiroyuki¹¹,Aoki Masashi²

Affiliation:

1. Department of NeurologyHanamaki General Hospital4‐28Kajoh‐chou Hanamaki025‐0075 Japan

2. Department of NeurologyTohoku University Graduate School of MedicineSendai Japan

3. Department of NeurologySendai Medical CenterSendai Japan

4. Department of NeurologySapporo Medical University HospitalSapporo Japan

5. Department of NeurologyHokkaido Medical CenterSapporo Japan

6. Department of NeurologyChiba University School of MedicineChiba Japan

7. Chiba Neurology ClinicChiba Japan

8. Department of NeurologyTokyo Medical UniversityTokyo Japan

9. Department of NeurologyToho University Oh‐hashi Medical CenterTokyo Japan

10. Department of NeurologyKinki University School of MedicineOsaka Japan

11. Department of Neurological therapeuticsKyushu University Graduate School of MedicineFukuoka Japan

Funder

Japan MG Registry Study Group

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Clinical Neurology,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mus.25397

Reference15 articles.

1. Long-term corticosteriod treatment of myasthenia gravis: Report of 116 Patients

2. Lifetime course of myasthenia gravis

3. Autoimmune myasthenia gravis

4. Immunosuppressive therapies in myasthenia gravis

5. The MG-QOL15 Japanese version: Validation and associations with clinical factors

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Case Series of Efgartigimod for Japanese Generalized Myasthenia Gravis: Well-Tailored Treatment Cycle Intervals Contribute to Sustained Symptom Control;Biomedicines;2024-05-30

2. Intravenous methylprednisolone therapy for ocular myasthenia gravis: A retrospective study;Neurology and Clinical Neuroscience;2024-03-29

3. Clinical features of double seronegative ocular myasthenia gravis;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-02-28

4. Dramatic improvement in refractory myasthenia gravis with eculizumab treatment: a case report;Journal of Neurology;2024-02-23

5. Efficacy of ravulizumab in patients with generalized myasthenia gravis by time from diagnosis: A post hoc subgroup analysis of the CHAMPION MG study;Muscle & Nerve;2024-02-21